Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma

Activators and target genes of Rel/NF-κB transcription factors

Heike L. Pahl · Oncogene · 1999 · 3.7K citations

Life Sciences, Genetics, Molecular Biology +14

Anticancer potential of curcumin: preclinical and clinical studies.

Bharat B. Aggarwal, Anushree Kumar, Alok C. Bharti · PubMed · 2003 · 2.6K citations

Medicine, Oncology, Pharmacology +15

NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase

Osman Nidai Özeş, Lindsey D. Mayo, Jason A. Gustin et al. · Nature · 1999 · 2.2K citations

Life Sciences, Cell Biology, Immunology +16

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations

Medicine, Oncology, Pharmacology +10

Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)

Sanjaya Singh, Bharat B. Aggarwal · Journal of Biological Chemistry · 1995 · 1.4K citations · Full text

Life Sciences, Immunology, Pharmacology +12